Moreover, TERF2 mRNA expression is inversely related to survival in breast carcinoma (P = 0.045), colon carcinoma (Overall survival; P = 0.008; Disease free survival; P < 0.001) and prostate adenocarcinoma (Overall survival; P = 0.002). Here, TERF2 is linked to colon carcinoma.